ArticleInternational journal of urology : official journal of the Japanese Urological Association2025

Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis.

Satoru Taguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.